J&J CEO Joaquin Duato on Q3 results: We are entering an era of accelerated growth
Johnson & Johnson chairman and CEO Joaquin Duato joins ‘Squawk Box’ to discuss the company’s quarterly earnings results, adding warning labels to its multiple myeloma treatment Carvykti, the decision to spin off its orthopedics business, state of the company talc lawsuits, and more.
